CURLFOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Curaleaf Holdings, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$7.63−0.20 (-2.55%)
Close on Oct 19, 2026
- Market cap
- $2.07B
- P/E (TTM)
- –
- Dividend yield
- –
Curaleaf Holdings, Inc. revenue by segment
By business segment
| Revenue | Q2 26 | Q4 25 | Q2 25 | Q4 24 | Q4 23 | Q4 22 | Q4 21 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Domestic | $288.70M | – | $269.68M | – | – | – | – | 84.9% | +7.1% |
| International | $51.40M | – | $40.91M | – | – | – | – | 15.1% | +25.7% |
By product or service
| Revenue | Q2 26 | Q4 25 | Q2 25 | Q4 24 | Q4 23 | Q4 22 | Q4 21 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Retail and wholesale revenues | $336.72M | – | $308.49M | – | – | – | – | 99.0% | +9.2% |
| Retail revenues | $240.73M | – | $229.31M | – | – | – | – | 70.8% | +5.0% |
| Wholesale revenues | $95.99M | – | $79.18M | – | – | – | – | 28.2% | +21.2% |
| Management fee income | $3.38M | – | $2.10M | – | – | – | – | 1.0% | +61.0% |
By region
From the segment and revenue-disaggregation notes of Curaleaf's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.